Skip to main content

Table 3 Number of cats with clinical signs associated with troglostrongylosis

From: Pilot study evaluating the efficacy of a topical formulation containing emodepside and praziquantel in the treatment of natural feline troglostrongylosis

Clinical signs Group Day 0
n (%)
Day 14
n (%)
Day 28
n (%)
Day 42
n (%)
Day 56
n (%)
Cough T 3 (37.5) 1 (12.5) 1 (12.5) 0 0
C 0 1 (12.5) 1 (12.5) 1 (12.5) 0
Pale mucous membranes T 1 (12.5) 1 (12.5) 0 0 0
C 0 0 1 (12.5) 2 (25.0) 0
Hyperthermia T 0 0 0 0 0
C 0 0 0 2 (25.0) 0
Ocular-nasal discharge T 2 (25.0) 1 (12.5) 1 (12.5) 0 0
C 1 (12.5) 2 (25.0) 2 (25.0) 3 (37.5) 1 (12.5)
Tachypnoea T 2 (25.0) 3 (37.5) 1 (12.5) 0 0
C 1 (12.5) 2 (25.0) 2 (25.0) 3 (37.5) 0
Dyspnoea T 3 (37.5) 1 (12.5) 1 (12.5) 0 0
C 0 1 (12.5) 1 (12.5) 3 (37.5) 0
Abnormal breath sounds on lung auscultation T 4 (50.0) 2 (25.0) 1 (12.5) 0 0
C 0 0 1 (12.5) 1 (12.5) 0
No. of cats with at least 1 sign T 5 (62.5) 3 (37.5) 2 (25.0) 0 0
C 2 (25.0) 3 (37.5) 3 (37.5) 3 (37.5) 1 (12.5)
  1. Note: Cats of Group T (n = 8); cats of Group C (n = 8)